# BYLVAY

NDC: 74528-040
Generic name: odevixibat
Labeler / Manufacturer: Albireo Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, COATED PELLETS
Routes: ORAL
Marketing started: 20210720

FDA application: NDA215498

## Active ingredients

- ODEVIXIBAT: 400 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"74528-040"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=74528-040
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=151f1d3e-2bf4-47ce-b1be-a892de3258fa